Equities

Xtant Medical Holdings Inc

Xtant Medical Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.72
  • Today's Change-0.025 / -3.38%
  • Shares traded114.78k
  • 1 Year change+16.49%
  • Beta0.3306
Data delayed at least 15 minutes, as of May 31 2024 21:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

  • Revenue in USD (TTM)101.23m
  • Net income in USD-1.66m
  • Incorporated2006
  • Employees207.00
  • Location
    Xtant Medical Holdings Inc664 Cruiser LaneBELGRADE 59714United StatesUSA
  • Phone+1 (406) 388-0480
  • Fax+1 (302) 636-5454
  • Websitehttps://xtantmedical.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
XTNT:ASQ since
announced
Transaction
value
Surgalign Holdings Inc-Hardware & Biomaterials Assets,USDeal completed09 Aug 202309 Aug 2023Deal completed-44.62%5.00m
Data delayed at least 15 minutes, as of May 31 2024 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Monogram Technologies Inc365.00k-13.39m63.02m28.00--6.16--172.67-0.4414-0.44140.0120.32330.0316----13,035.71-115.81-119.26-226.52-257.400.00---3,669.37-5,045.60----0.00-------0.3964---15.97--
Pro-Dex Inc49.46m4.35m67.39m146.0016.232.2012.341.361.211.2113.878.961.012.434.23338,753.408.9115.4311.2918.8727.9433.158.7914.922.0811.980.27510.009.6215.4654.7232.380.8422--
InspireMD Inc6.48m-22.69m68.56m65.00--1.83--10.58-0.7594-0.75940.21081.500.20912.344.9799,646.16-73.26-60.59-86.14-72.9726.6520.46-350.35-334.787.41--0.00--20.0011.50-7.71--41.57--
IR-Med Inc0.00-4.22m69.98m6.00---------0.0608-0.06080.00-0.00120.00----0.00-285.64---463.30--------------2.16-------3.70------
Vivos Inc18.00k-3.20m69.98m10.00--52.16--3,887.80-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Heartbeam Inc0.00-15.11m73.19m15.00--5.84-----0.6111-0.61110.000.47620.00----0.00-200.17---258.74--------------0.00-------12.94------
T2 Biosystems Inc7.18m-45.65m78.98m113.00------11.01-17.91-17.912.21-6.850.24973.244.9363,504.43-158.80-106.01---253.03-116.97-12.60-636.09-317.930.1936--10.70---67.75-7.2919.66---20.19--
Vuzix Corp9.94m-49.96m86.73m94.00--1.19--8.72-0.7826-0.78260.15581.130.09971.302.52105,762.30-50.09-41.61-54.56-44.80-35.85-6.13-502.49-317.286.57--0.00--2.488.42-23.02--39.42--
Sensus Healthcare Inc31.66m4.65m88.85m35.0019.011.7418.042.810.28510.28511.943.120.57211.021.96904,428.608.4110.299.4012.1460.3462.8514.7015.296.49--0.00---45.20-1.58-98.00---23.16--
Vivani Medical Inc0.00-25.37m89.61m44.00--3.12-----0.4954-0.49540.000.52220.00----0.00-51.59-56.58-58.76-67.66-------2,868.72----0.00-------84.69--40.33--
Xtant Medical Holdings Inc101.23m-1.66m93.76m207.00--1.9745.820.9262-0.0189-0.01890.80190.36621.291.366.06489,043.50-2.11-10.38-2.98-14.6861.4761.08-1.64-8.660.978-4.140.3638--57.504.81107.78--18.47--
KORU Medical Systems Inc29.32m-13.27m97.48m82.00--5.09--3.32-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Myomo Inc19.55m-9.34m98.26m101.00--9.01--5.03-0.2676-0.26760.57750.37861.293.2312.10193,552.80-61.73-81.78-89.94-115.2767.3968.50-47.77-85.762.40--0.00--23.7051.0924.00--2.82--
Fonar Corp102.72m10.29m104.62m561.0010.530.63125.551.021.481.4814.7224.700.502319.991.41183,098.207.168.737.409.6045.5548.3314.2616.399.16--0.0051--1.083.89-24.71-15.058.48--
Akoya Biosciences Inc93.57m-68.01m106.18m330.00--3.24--1.13-1.47-1.471.990.66320.60562.207.08283,554.50-44.01---56.06--55.99---72.68--2.38-10.150.7013--29.09--10.36------
Data as of May 31 2024. Currency figures normalised to Xtant Medical Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

12.46%Per cent of shares held by top holders
HolderShares% Held
Altium Capital Management LPas of 31 Mar 20247.65m5.87%
Nantahala Capital Management LLCas of 31 Mar 20244.00m3.07%
The Vanguard Group, Inc.as of 31 Mar 20241.55m1.19%
Renaissance Technologies LLCas of 31 Mar 2024763.31k0.59%
AMH Equity Ltd.as of 31 Mar 2024500.00k0.38%
AWM Investment Co., Inc.as of 31 Mar 2024378.21k0.29%
Bridgeway Capital Management LLCas of 31 Mar 2024368.50k0.28%
Susquehanna Financial Group LLLPas of 31 Mar 2024350.85k0.27%
Juniper Investment Co. LLCas of 31 Mar 2024348.40k0.27%
Geode Capital Management LLCas of 31 Mar 2024316.16k0.24%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.